The aim of this study is to assess the dermatological and ophthalmological tolerance of the investigational product Baume visage / Face balm RV4942A - RY1985 after 21 days of twice daily use on the study areas, under normal conditions of use. The aim of this study is also to: * evaluate the cutaneous sensitivity by a stinging test at D1 T0 and D22. * evaluate the cutaneous sensitivity by a sensitive scale at D1 T0, D1 Timm\*, D8 and D22. * evaluate the soothing efficacy by an efficacy questionnaire at D1 Timm\*, D8 and D22. * evaluate the cosmetic acceptability by a questionnaire at D22. This study is conducted as a national, monocentric, non-randomized open trial. The 33 subjects in this study (31 subjects on D22) present hypersensitive, reactive and intolerant skin on face. They are stinger subjects, with a dry to very dry skin. Timm\*: 10 to 30 minutes after first application
his study is a national, monocentric, non-randomized open trial, conducted in adults presenting hypersensitive, reactive and intolerant skin on the face, with a dry to very dry skin. The study includes 3 visits, including subjects' selection: * V1: Baseline inclusion * V2: 1 week, intermediate visit * V3: 3 weeks, study end The maximal study duration is 25 days. The evaluation is at 3 times: D1 baseline, D8 at 1 week and D22 at 3 weeks of application of RV4942A - RY1985 with comparison of each time versus baseline. There are twice-daily applications (morning and evening) of the test product on the face.
Study Type
OBSERVATIONAL
Enrollment
33
RV4942A is a face balm product
Eurofins China
Guangzhou, Haizhu District, China
Global tolerance assessment of the investigational product by dermatological evaluation
Dermatological evaluation based on physical and functional signs assessment by the dermatologist
Time frame: Change from baseline to just after application and to 3 weeks later
Global tolerance assessment of the investigational product by ophthalmological evaluation
Ophthalmological evaluation based on physical and functional signs assessment by the ophthalmologist
Time frame: Change from baseline to just after application and to 3 weeks later
Cutaneous sensitivity by stinging test
Stinging test is an in vivo methodology that evaluates sensitive skin and consists in application of 10% lactic acid on one nasolabial fold of subject's nasogenian folds
Time frame: Change from baseline to 3 weeks later
Cutaneous sensitivity by sensitivity scale questionnaire
Subjects assess the degree of their overall face skin irritation using an Analogue Visual Scale and fill out the sensitivity scale questionnaire regarding physical and functional cutaneous signs to score from 0 to 10.
Time frame: Change from baseline to 1 week and to 3 weeks later
Soothing efficacy by a questionnaire
Subjects evaluate the soothing effect of the investigational product with a questionnaire
Time frame: Change from just after application to 1 week and to 3 weeks later
Cosmetic acceptability and efficacy perceived questionnaire
Questionnaire with open questions and scales ranging from 0 to 10 where 0 was the worst satisfaction and 10 the best one.
Time frame: After 3 weeks of tested product
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.